This dynamic module can offer access to drug dispensing data, drug utilization data, and de-identified patient demographic data that can be utilized by various interested stakeholders: specialty pharmacies, pharmaceutical manufacturers, home infusion pharmacies, payers, chain drug stores, physicians, hospitals, and other health care groups tracking adherence and specialty drug compliance
Eisai has developed the new triple formulation pack for primary and secondary eradication that includes three separate formulations in a single package in order to help ensure that eradication therapy will be carried out more appropriately and with greater certainty, improve patient drug compliance
and offer increased levels of convenience in the medical setting.
This year, we've expanded our coverage to also assess drug compliance
Push for Lower-Cost Therapies, Screenings and Drug Compliance
Will Drive Savings Efforts, According to a New Report from Decision Resources
These characteristic features are expected to improve drug compliance
amongst patients, while at the same time reducing the burden on caregivers who help administer the drug to patients.
As trials become more complex and the workload at investigator sites increases, sponsors are looking for more efficient ways to monitor patient drug compliance
, centralize data collected at the sites and decrease the paper trail.
14, 2011 /PRNewswire/ -- In an effort to boost prescription drug compliance
, Rexam Prescription Products has joined with Easy Way, LLC, to help promote the Didit - one of the world's leading tools to help eliminate the guesswork and confusion of taking prescription medications.
Through the addition of the new oral jelly formulation that aims to further improve drug compliance
among AD patients, Eisai will continue to make further contributions to increasing the benefits of patients, and their families and caregivers.
Care coordination in medical homes is likely to enhance prescription drug compliance
because of an emphasis on managing chronic conditions," said HealthLeaders-InterStudy Senior Analyst Chris Lewis.
The new report states that parasite reemergence has resulted from global warming, urbanization and subsequent changes in livestock systems, while severe side effects, hypersensitivity and drug compliance
issues in congenital cases are increasing patient dissatisfaction with current treatment methods.
Employers realize that continuing to increase copays could likely lead to lower drug compliance
, which may eventually mean higher medical costs and reduced productivity due to illness.
The pharmaceutical industry will benefit from an increased focus on prescription drug compliance
and quality health outcomes.